INTELLIGENT BIO SOLUTIONS INC(INBS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

INBS INTELLIGENT BIO SOLUTIONS INC

Pre-Mkt 12-19 07:33:33 EST

6.99

+1.09

+18.37%

盘前6.97

-0.02-0.29%

06:58 EST

High7.25	Low6.23	Vol297.92K
Open6.23	D1 Closing5.91	Amplitude17.31%
Mkt Cap6.71M	Tradable Cap6.07M	Total Shares959.50K
T/O2.01M	T/O Rate34.31%	Tradable Shares868.43K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"INBS","market":"US","secType":"STK","nameCN":"INTELLIGENT BIO SOLUTIONS INC","latestPrice":6.99,"timestamp":1766091600000,"preClose":5.905,"halted":0,"volume":297920,"hourTrading":{"tag":"盘前","latestPrice":6.97,"preClose":6.99,"latestTime":"06:58 EST","volume":3,"amount":20.91,"timestamp":1766145521118},"delay":0,"floatShares":868430,"shares":959500,"eps":-20.04066,"marketStatus":"Pre-Mkt","change":1.085,"latestTime":"12-19 07:33:33 EST","open":6.23,"high":7.252,"low":6.23,"amount":2007233.795392,"amplitude":0.173074,"askPrice":7.25,"askSize":2,"bidPrice":6.4,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-20.04066,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1766154600000},"marketStatusCode":1,"adr":0,"listingDate":1608699600000,"exchange":"NASDAQ","adjPreClose":6.99,"preHourTrading":{"tag":"盘前","latestPrice":6.97,"preClose":6.99,"latestTime":"06:58 EST","volume":3,"amount":20.91,"timestamp":1766145521118},"postHourTrading":{"tag":"盘后","latestPrice":6.8,"preClose":6.99,"latestTime":"19:50 EST","volume":1358,"amount":9311.09,"timestamp":1766105425364},"volumeRatio":5.135135147526871},"requestUrl":"/m/hq/s/INBS/tweets","defaultTab":"tweets","newsList":[{"id":"2592909576","title":"Intelligent Bio Solutions Partners with Vlepis to Expand Non-Invasive Health Monitoring","url":"https://stock-news.laohu8.com/highlight/detail?id=2592909576","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592909576?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:30","pubTimestamp":1766064634,"startTime":"0","endTime":"0","summary":"Intelligent Bio Solutions Inc. has announced a non-exclusive strategic partnership with Vlepis Pty Ltd, an Australian company specializing in advanced sensing and wearable patch technologies. The collaboration aims to drive innovation in non-invasive screening and consumer health monitoring by leveraging both companies’ research and development, distribution, and regulatory expertise. This alliance will allow Intelligent Bio Solutions to expand into the fast-growing consumer health market, broadening its revenue opportunities beyond commercial screening. The partnership also includes plans to integrate Vlepis’ wearable technologies and software with Intelligent Bio Solutions’ existing product portfolio, potentially accelerating international sales and expanding applications into both business and consumer health sectors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nNDLf1bJ5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU0314104364.USD","LU2095319765.USD","SG9999014013.SGD","BK4585","LU2210150020.SGD","INBS","NDAQ","SG9999014021.USD","SG9999014039.USD","BK4082","IE00BGHQF748.EUR","BK4112","LU2210149790.SGD","SG9999014005.SGD","IE00BKPKM429.USD","IE00B3QW5Z07.USD","BK4588"],"gpt_icon":0},{"id":"2592958923","title":"Intelligent Bio Solutions Faces Nasdaq Delisting Risk Over Sub-$1 Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2592958923","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592958923?lang=en_us&edition=fundamental","pubTime":"2025-12-17 06:16","pubTimestamp":1765923364,"startTime":"0","endTime":"0","summary":"Intelligent Bio Solutions Inc. has received a deficiency letter from the Nasdaq Listing Qualifications Department, notifying the company that its common stock has traded below the $1.00 per share minimum bid price required for continued listing on the Nasdaq Capital Market. The company now has 180 calendar days, until June 15, 2026, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. To address the issue, Intelligent Bio Solutions implemented a 1-for-10 reverse stock split, effective December 15, 2025. If compliance is not achieved within the initial period, the company may qualify for an additional 180-day extension, but failure to meet requirements could result in delisting from Nasdaq.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nNDL7zwBDS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBS","BK4082"],"gpt_icon":0},{"id":"2591675893","title":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:50 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2591675893","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591675893?lang=en_us&edition=fundamental","pubTime":"2025-12-16 08:50","pubTimestamp":1765846200,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  HALT NEWS PENDING AT 07:50 PM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nAQN2LDOFS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBS","BK4082"],"gpt_icon":0},{"id":"2590818500","title":"Intelligent Bio Solutions Announces 1-for-10 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2590818500","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590818500?lang=en_us&edition=fundamental","pubTime":"2025-12-12 23:30","pubTimestamp":1765553411,"startTime":"0","endTime":"0","summary":"Intelligent Bio Solutions Inc. has announced a 1-for-10 reverse stock split of its common stock, effective at 11:59 pm Eastern Time on December 15, 2025. The company's shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market under the symbol \"INBS\" on December 16, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via GlobeNewswire  on December 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nNDLcdgq74:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014013.SGD","BK4112","IE00BKPKM429.USD","IE00B64PRP62.GBP","BK4585","BK4082","SG9999014021.USD","LU2210149790.SGD","BK4588","SG9999014005.SGD","LU2210150020.SGD","SG9999014039.USD","LU2095319765.USD","INBS","LU0314104364.USD","NDAQ","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2590507044","title":"Intelligent Bio Solutions Inc. Announces Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2590507044","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590507044?lang=en_us&edition=fundamental","pubTime":"2025-12-12 23:30","pubTimestamp":1765553400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251212:nTUA2K24PR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","INBS"],"gpt_icon":0},{"id":"2588706665","title":"Intelligent Bio Solutions Inc. Unveils Non-Invasive Drug Testing Technology in Investor Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2588706665","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588706665?lang=en_us&edition=fundamental","pubTime":"2025-12-02 06:37","pubTimestamp":1764628632,"startTime":"0","endTime":"0","summary":"Intelligent Bio Solutions Inc. has released a presentation detailing its advancements in drug testing technology. The company highlighted its Intelligent Fingerprinting Drug Screening System, which utilizes fingerprint sweat analysis to detect recent drug use. The system is designed to be non-invasive, portable, and efficient, with the capability to screen for substances such as opiates, cocaine, methamphetamine, and cannabis. According to the presentation, the process involves collecting fingerprint sweat samples, which are then analyzed to provide results in less than 10 minutes. The technology aims to reduce costs, improve testing efficiency, and enhance sample integrity while maintaining privacy and dignity for individuals being tested. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL9CWYdT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","INBS"],"gpt_icon":0},{"id":"2587730287","title":"Intelligent Bio Solutions Issues 75,000 Shares to MDM for Advisory Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2587730287","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587730287?lang=en_us&edition=fundamental","pubTime":"2025-11-29 06:01","pubTimestamp":1764367274,"startTime":"0","endTime":"0","summary":"Intelligent Bio Solutions Inc. has announced the issuance of 75,000 restricted shares of its common stock to MDM Worldwide Solutions, Inc. as equity compensation. The shares were granted in connection with an agreement for MDM to provide strategic communication advisory and consulting services to the company. No cash proceeds were received for the shares, which were issued under an exemption from registration pursuant to Section 4 of the Securities Act of 1933.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on Nov","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251128:nNDL2Mwtf1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","INBS"],"gpt_icon":0},{"id":"2584323041","title":"Intelligent Bio Solutions Inc. to Present at Noble Capital Markets' Emerging Growth Equity Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2584323041","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584323041?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:31","pubTimestamp":1763645473,"startTime":"0","endTime":"0","summary":"Intelligent Bio Solutions Inc., a medical technology company specializing in rapid, non-invasive testing solutions, will participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference at Florida Atlantic University in Boca Raton, Florida, on December 2-3, 2025. The company is scheduled to present on December 3 at 11:00 a.m. Eastern Time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via Newsfile  on November 20, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL3Lysz1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","INBS"],"gpt_icon":0},{"id":"2582374843","title":"Press Release: Intelligent Bio Solutions Reports Fiscal 2026 First Quarter Financial Results and Operational Highlights, Delivering Record Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2582374843","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582374843?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:30","pubTimestamp":1762954200,"startTime":"0","endTime":"0","summary":"Record quarterly revenue of $1.11 million, an increase of 32% sequentially and 28% year-over-year, driven by consumable cartridge sales and customer base expansion. Gross profit margins increased 690 basis points year-over-year to 46.6%, reflecting improved operational efficiency and greater revenue percentage from higher margin cartridge sales. NEW YORK, Nov. 12, 2025  -- Intelligent Bio Solutions Inc.  , a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial results and operational highlights for the fiscal first quarter ended September 30, 2025.\"Our first quarter results show accelerating momentum of our business model and the growing market adoption internationally of our non-invasive drug screening technology,\" said Harry Simeonidis, President and CEO at Intelligent Bio Solutions. \"We achieved record quarterly revenue of $1.11 million, representing our strongest quarter to date, with 32% growth sequentially and 28%","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBS","BK4082","BK4022","R","BK4232"],"gpt_icon":0},{"id":"2582712613","title":"Intelligent Bio Solutions Inc. reports Q3 sales of $1.11 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582712613","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582712613?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:21","pubTimestamp":1762953700,"startTime":"0","endTime":"0","summary":"Intelligent Bio Solutions Inc. reported revenue from sales of goods of $1.1 million for the three months ended September 30, 2025, an increase of $0.2 million from $0.9 million in the same period in 2024, mainly due to expansion of the customer base. The company recorded a net loss attributable to Intelligent Bio Solutions Inc. of $3.0 million for the quarter, compared to a net loss of $2.7 million in the prior-year period. Total operating expenses rose to $3.7 million from $3.2 million year-over-year. The company reported a comprehensive loss of $2.9 million, up from $2.5 million in the previous year. Expansion into new markets is expected to continue.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. publi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL4pwrQB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","INBS"],"gpt_icon":0},{"id":"2580157732","title":"Intelligent Bio Solutions Expects to Report Record Fiscal First Quarter 2026 Revenue of Over $1 Million, an Increase of Approximately 32% Sequentially and 28% Year-Over-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2580157732","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580157732?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:30","pubTimestamp":1762263000,"startTime":"0","endTime":"0","summary":"Company Achieves Third Consecutive Quarter of Revenue Growth  Revenue Increase of Approximately 32% Sequentially and 28% Year-Over-Year Driven by New Customer Accounts and Strong Cartridge and Reader ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/04/3180349/0/en/Intelligent-Bio-Solutions-Expects-to-Report-Record-Fiscal-First-Quarter-2026-Revenue-of-Over-1-Million-an-Increase-of-Approximately-32-Sequentially-and-28-Year-Over-Year.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBS","BK4082"],"gpt_icon":0},{"id":"2579415411","title":"Intelligent Bio Solutions Inc:  Added 33 New Customer Accounts During Its Fiscal Q1, up 50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579415411","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579415411?lang=en_us&edition=fundamental","pubTime":"2025-10-30 20:33","pubTimestamp":1761827592,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nFWN3WB2KB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","INBS"],"gpt_icon":0},{"id":"2579612141","title":"Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480","url":"https://stock-news.laohu8.com/highlight/detail?id=2579612141","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579612141?lang=en_us&edition=fundamental","pubTime":"2025-10-30 20:30","pubTimestamp":1761827400,"startTime":"0","endTime":"0","summary":"NEW YORK, Oct.  30, 2025  (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (\"INBS\" or the \"Company\"), a medical technology company delivering intelligent, rapid, non-invasive testing ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/30/3177393/0/en/Intelligent-Bio-Solutions-Secures-33-New-Customer-Accounts-in-the-Fiscal-2026-First-Quarter-Showing-Strong-Year-Over-Year-Growth-and-Increasing-Total-Active-Accounts-to-480.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBS","BK4082","TSS"],"gpt_icon":0},{"id":"2577304909","title":"BRIEF-Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider","url":"https://stock-news.laohu8.com/highlight/detail?id=2577304909","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577304909?lang=en_us&edition=fundamental","pubTime":"2025-10-23 20:34","pubTimestamp":1761222870,"startTime":"0","endTime":"0","summary":"BRIEF-Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service ProviderOct 23 (Reuters) - Intelligent Bio Solutions Inc INBS.O:INTELLIGENT BIO SOLUTIONS SECURES MAJOR ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251023:nTUA2GQF3Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","INBS"],"gpt_icon":0},{"id":"2577802942","title":"Intelligent Bio Solutions Inc. held annual stockholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2577802942","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577802942?lang=en_us&edition=fundamental","pubTime":"2025-10-22 04:31","pubTimestamp":1761078706,"startTime":"0","endTime":"0","summary":"Intelligent Bio Solutions Inc. held its annual meeting of stockholders on October 16, 2025. Shareholders elected Stephen Boyages, Jonathan Hurd, Jason Isenberg, and Nicola Fraser to the board of directors. The appointment of UHY LLP as independent registered public accounting firm for the fiscal year ending June 30, 2026 was ratified. An amendment to increase the number of shares available under the company's 2019 Long Term Incentive Plan was also approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nNDL8jhFGp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INBS","BK4082"],"gpt_icon":0},{"id":"2570885911","title":"Intelligent Bio Solutions Inc - Anticipates FDA 510(K) Clearance in Second Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2570885911","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570885911?lang=en_us&edition=fundamental","pubTime":"2025-09-26 20:32","pubTimestamp":1758889938,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250926:nFWN3VC1U7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","INBS"],"gpt_icon":0},{"id":"2570885438","title":"Intelligent Bio Solutions Advances Preparations and Provides Updated Timeline for Anticipated FDA 510(k) Submission and Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2570885438","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570885438?lang=en_us&edition=fundamental","pubTime":"2025-09-26 20:30","pubTimestamp":1758889800,"startTime":"0","endTime":"0","summary":"The Company is initiating clinical studies to further validate Intelligent Fingerprinting Drug Screening System INBS anticipates FDA 510(k) clearance in the second half of 2026 NEW YORK, Sept.  26, 20","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/26/3157009/0/en/Intelligent-Bio-Solutions-Advances-Preparations-and-Provides-Updated-Timeline-for-Anticipated-FDA-510-k-Submission-and-Clearance.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","INBS"],"gpt_icon":0},{"id":"2569671237","title":"Intelligent Bio Solutions Inc. Announces Date for Upcoming Virtual Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2569671237","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569671237?lang=en_us&edition=fundamental","pubTime":"2025-09-24 00:31","pubTimestamp":1758645098,"startTime":"0","endTime":"0","summary":"Intelligent Bio Solutions Inc. has announced its annual meeting of stockholders, which will be held virtually on October 16, 2025. The meeting will serve as a platform for the company's stockholders to engage with the Board of Directors. Further details about the resolutions or proposals to be voted on during the meeting have not been disclosed.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Intelligent Bio Solutions Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 19, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250923:nNDL2lkQ11:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","INBS"],"gpt_icon":0},{"id":"2568496681","title":"Intelligent Bio Solutions - FDA Requests New Additional Information That Requires Co to Resubmit New 510(K) Notification","url":"https://stock-news.laohu8.com/highlight/detail?id=2568496681","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568496681?lang=en_us&edition=fundamental","pubTime":"2025-09-17 20:30","pubTimestamp":1758112200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nTUA2FYJTM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["INBS","BK4082"],"gpt_icon":0},{"id":"2568496632","title":"Intelligent Bio Solutions - Expects Investor Update in Ten Days Outlining Updated Timeline for FDA Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2568496632","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568496632?lang=en_us&edition=fundamental","pubTime":"2025-09-17 20:30","pubTimestamp":1758112200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250917:nTUA2FYJTM:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","INBS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ibs.inc","stockEarnings":[{"period":"1week","weight":-0.0353},{"period":"1month","weight":0.013},{"period":"3month","weight":-0.4705},{"period":"6month","weight":-0.6073},{"period":"1year","weight":-0.4496},{"period":"ytd","weight":-0.5007}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.558125},{"month":2,"riseRate":0.4,"avgChangeRate":-0.025376},{"month":3,"riseRate":0.2,"avgChangeRate":-0.073691},{"month":4,"riseRate":0,"avgChangeRate":-0.232721},{"month":5,"riseRate":0.4,"avgChangeRate":-0.035776},{"month":6,"riseRate":0.8,"avgChangeRate":0.101109},{"month":7,"riseRate":0.2,"avgChangeRate":-0.159016},{"month":8,"riseRate":0.4,"avgChangeRate":-0.021927},{"month":9,"riseRate":0.2,"avgChangeRate":-0.2238},{"month":10,"riseRate":0.2,"avgChangeRate":-0.237733},{"month":11,"riseRate":0.4,"avgChangeRate":0.114439},{"month":12,"riseRate":0.2,"avgChangeRate":-0.194899}],"exchange":"NASDAQ","name":"INTELLIGENT BIO SOLUTIONS INC","nameEN":"INTELLIGENT BIO SOLUTIONS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"INTELLIGENT BIO SOLUTIONS INC(INBS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest INTELLIGENT BIO SOLUTIONS INC(INBS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"INTELLIGENT BIO SOLUTIONS INC,INBS,INTELLIGENT BIO SOLUTIONS INC股票,INTELLIGENT BIO SOLUTIONS INC股票老虎,INTELLIGENT BIO SOLUTIONS INC股票老虎国际,INTELLIGENT BIO SOLUTIONS INC行情,INTELLIGENT BIO SOLUTIONS INC股票行情,INTELLIGENT BIO SOLUTIONS INC股价,INTELLIGENT BIO SOLUTIONS INC股市,INTELLIGENT BIO SOLUTIONS INC股票价格,INTELLIGENT BIO SOLUTIONS INC股票交易,INTELLIGENT BIO SOLUTIONS INC股票购买,INTELLIGENT BIO SOLUTIONS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"INTELLIGENT BIO SOLUTIONS INC(INBS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest INTELLIGENT BIO SOLUTIONS INC(INBS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction